View in EDS

Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: a meta-analysis.

Saved in:
Bibliographic Details
Title: Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: a meta-analysis.
Authors: Yanagisawa T; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Department of Urology, The Jikei University School of Medicine, Tokyo, 105-8461, Japan., Quhal F; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Department of Urology, King Fahad Specialist Hospital, Dammam, 32253, Saudi Arabia., Kawada T; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Okayama, 700-8530, Japan., Bekku K; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Okayama, 700-8530, Japan., Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Institute for Urology & Reproductive Health, Sechenov University, Moscow, 119435, Russia., Rajwa P; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Department of Urology, Medical University of Silesia, Zabrze, 41-800, Poland., Deimling MV; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, 20251, Germany., Chlosta M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Clinic of Urology & Urological Oncology, Jagiellonian University, Krakow, 30-688, Poland., Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Department of Urology, La Croix Du Sud Hospital, Quint Fonsegrives, 31130, France., Karakiewicz PI; Cancer Prognostics & Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, H2X 0A9, Canada., Mori K; Department of Urology, The Jikei University School of Medicine, Tokyo, 105-8461, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, 105-8461, Japan., Schmidinger M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Division of Urology, Department of Special Surgery, The University of Jordan, Amman, 19328, Jordan.; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, 15006, Czech Republic.; Department of Urology, Weill Cornell Medical College, NY 10021, USA.; Karl Landsteiner Institute of Urology & Andrology, Vienna, 1090, Austria.
Source: Immunotherapy [Immunotherapy] 2023 Oct; Vol. 15 (15), pp. 1309-1322. Date of Electronic Publication: 2023 Sep 11.
Publication Type: Meta-Analysis; Journal Article; Review
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485158 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-7448 (Electronic) Linking ISSN: 1750743X NLM ISO Abbreviation: Immunotherapy Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37694583
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: a meta-analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yanagisawa+T%22">Yanagisawa T</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Department of Urology, The Jikei University School of Medicine, Tokyo, 105-8461, Japan.<br /><searchLink fieldCode="AU" term="%22Quhal+F%22">Quhal F</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Department of Urology, King Fahad Specialist Hospital, Dammam, 32253, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Kawada+T%22">Kawada T</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Okayama, 700-8530, Japan.<br /><searchLink fieldCode="AU" term="%22Bekku+K%22">Bekku K</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Okayama, 700-8530, Japan.<br /><searchLink fieldCode="AU" term="%22Laukhtina+E%22">Laukhtina E</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Institute for Urology & Reproductive Health, Sechenov University, Moscow, 119435, Russia.<br /><searchLink fieldCode="AU" term="%22Rajwa+P%22">Rajwa P</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Department of Urology, Medical University of Silesia, Zabrze, 41-800, Poland.<br /><searchLink fieldCode="AU" term="%22Deimling+MV%22">Deimling MV</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, 20251, Germany.<br /><searchLink fieldCode="AU" term="%22Chlosta+M%22">Chlosta M</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Clinic of Urology & Urological Oncology, Jagiellonian University, Krakow, 30-688, Poland.<br /><searchLink fieldCode="AU" term="%22Pradere+B%22">Pradere B</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Department of Urology, La Croix Du Sud Hospital, Quint Fonsegrives, 31130, France.<br /><searchLink fieldCode="AU" term="%22Karakiewicz+PI%22">Karakiewicz PI</searchLink>; Cancer Prognostics & Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, H2X 0A9, Canada.<br /><searchLink fieldCode="AU" term="%22Mori+K%22">Mori K</searchLink>; Department of Urology, The Jikei University School of Medicine, Tokyo, 105-8461, Japan.<br /><searchLink fieldCode="AU" term="%22Kimura+T%22">Kimura T</searchLink>; Department of Urology, The Jikei University School of Medicine, Tokyo, 105-8461, Japan.<br /><searchLink fieldCode="AU" term="%22Schmidinger+M%22">Schmidinger M</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.<br /><searchLink fieldCode="AU" term="%22Shariat+SF%22">Shariat SF</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.; Division of Urology, Department of Special Surgery, The University of Jordan, Amman, 19328, Jordan.; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, 15006, Czech Republic.; Department of Urology, Weill Cornell Medical College, NY 10021, USA.; Karl Landsteiner Institute of Urology & Andrology, Vienna, 1090, Austria.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101485158%22">Immunotherapy</searchLink> [Immunotherapy] 2023 Oct; Vol. 15 (15), pp. 1309-1322. <i>Date of Electronic Publication: </i>2023 Sep 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Meta-Analysis; Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101485158 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1750-7448 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221750743X%22">1750743X </searchLink><i>NLM ISO Abbreviation: </i>Immunotherapy <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37694583
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2217/imt-2023-0039
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1309
    Titles:
      – TitleFull: Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: a meta-analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yanagisawa T
      – PersonEntity:
          Name:
            NameFull: Quhal F
      – PersonEntity:
          Name:
            NameFull: Kawada T
      – PersonEntity:
          Name:
            NameFull: Bekku K
      – PersonEntity:
          Name:
            NameFull: Laukhtina E
      – PersonEntity:
          Name:
            NameFull: Rajwa P
      – PersonEntity:
          Name:
            NameFull: Deimling MV
      – PersonEntity:
          Name:
            NameFull: Chlosta M
      – PersonEntity:
          Name:
            NameFull: Pradere B
      – PersonEntity:
          Name:
            NameFull: Karakiewicz PI
      – PersonEntity:
          Name:
            NameFull: Mori K
      – PersonEntity:
          Name:
            NameFull: Kimura T
      – PersonEntity:
          Name:
            NameFull: Schmidinger M
      – PersonEntity:
          Name:
            NameFull: Shariat SF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2023 Oct
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1750-7448
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 15
          Titles:
            – TitleFull: Immunotherapy
              Type: main
ResultId 1